tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
PremiumThe FlyAmphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
28d ago
AMPH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
28d ago
Amphastar Licenses ACTH Analog AMP-110 for North America
Premium
Company Announcements
Amphastar Licenses ACTH Analog AMP-110 for North America
2M ago
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
PremiumCompany AnnouncementsAmphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
4M ago
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
5M ago
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
Premium
Company Announcements
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
5M ago
Amphastar price target lowered to $31 from $32 at BofA
PremiumThe FlyAmphastar price target lowered to $31 from $32 at BofA
6M ago
Amphastar Signs $2.8M Research Agreement with Hanxin
Premium
Company Announcements
Amphastar Signs $2.8M Research Agreement with Hanxin
6M ago
Amphastar price target raised to $32 from $28 at BofA
Premium
The Fly
Amphastar price target raised to $32 from $28 at BofA
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100